FDA’s ORA Undergoing Changes To Keep Up With Globalization – Glavin
This article was originally published in The Tan Sheet
Executive Summary
FDA's Office of Regulatory Affairs will undergo "significant modifications" to its operations and structure to manage growing responsibilities amid shrinking resources, according to ORA Associate Commissioner Margaret O'K. Glavin
You may also be interested in...
Avoiding GMP “Showstoppers” Keeps Manufacturers Off FDA’s “Radar”
Compliance consultants warn that certain dietary supplement good manufacturing practices violations are inspection "showstoppers" and will draw agency enforcement
Avoiding GMP “Showstoppers” Keeps Manufacturers Off FDA’s “Radar”
Compliance consultants warn that certain dietary supplement good manufacturing practices violations are inspection "showstoppers" and will draw agency enforcement
Chattem’s Financing Strategy Keeps Door Open For Acquisitions
Chattem remains in the hunt for acquisitions because its preferred financing strategy continues to be attractive even with lending activity slowed worldwide, according to President and Chief Operating Officer Bob Bosworth